COVAXIN overall 77.8% effective in Phase-3 trial : Bharat Biotech

Name: COVAXIN overall 77.8% effective in Phase-3 trial : Bharat Biotech
Uploaded: 2021-07-03T08:47:31+00:00
Duration: 1 min 33 s
Channel: NYOOOZ TV
Description: Bharat Biotech's Covaxin is overall 77.8 percent effective against Covid, the vaccine maker tweeted today, citing the data from the third phase of clinical trials.

NYOOOZ TV

Bharat Biotech's Covaxin is overall 77.8 percent effective against Covid, the vaccine maker tweeted today, citing the data from the third phase of clinical trials.

Category

Comments

Recommended